These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18485582)
1. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy. what can they teach us? Scattoni V Eur Urol; 2009 Apr; 55(4):910. PubMed ID: 18485582 [No Abstract] [Full Text] [Related]
2. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us? Stanislaus P; Seitz M Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577 [No Abstract] [Full Text] [Related]
3. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us? Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578 [TBL] [Abstract][Full Text] [Related]
4. Editorial comment on: Improved accuracy in predicting the presence of gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Remzi M Eur Urol; 2007 Dec; 52(6):1668-9. PubMed ID: 17240039 [No Abstract] [Full Text] [Related]
5. [Conformal radiotherapy of prostate cancers]. de Crevoisier R Soins; 2007 Mar; (713):40-1. PubMed ID: 17419569 [No Abstract] [Full Text] [Related]
6. Three-dimensional conformal radiation therapy for early prostate cancer. Peschel RE Cancer J Sci Am; 1999; 5(3):145-6. PubMed ID: 10367168 [No Abstract] [Full Text] [Related]
7. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique. Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004 [TBL] [Abstract][Full Text] [Related]
9. Profound bicalutamide withdrawal syndrome in a hormone-refractory T4N1 prostate cancer permitting both salvage radiotherapy and cessation of hormonal therapy. Takeshita H; Kawakami S; Fukui I Int J Urol; 2009 Mar; 16(3):337-8. PubMed ID: 19298352 [No Abstract] [Full Text] [Related]
10. Re: Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer: M. J. Zelefsky, V. E. Reuter, Z. Fuks, P. Scardino and A. Shippy. J Urol 2008; 179: 1368-1373. Coquard R J Urol; 2008 Nov; 180(5):2258; author reply 2258. PubMed ID: 18804799 [No Abstract] [Full Text] [Related]
11. Editorial comment. Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Jones JS Urology; 2011 Mar; 77(3):552. PubMed ID: 21377001 [No Abstract] [Full Text] [Related]
18. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638 [TBL] [Abstract][Full Text] [Related]
19. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572 [TBL] [Abstract][Full Text] [Related]